Search

This year, young researchers from Berlin were once again drawn to the regional competition "Jugend forscht". Pictures and videos provide insight into the colorful competition on the Berlin-Buch Campus.

Cryo-electron microscopy allows structural biologists to look at the most minute building blocks of life. We celebrated the opening of the joint Core Facility and the corresponding research building of Charité – Universitätsmedizin Berlin and the Max Delbrück Center with a symposium.

Dr. Isolde Dietrich was instrumental in developing cryo-electron microscopy. But who was she? One thing is certain: physics was her passion. And she wanted to make it easier for younger female colleagues to enter science. The Max Delbrück Center is now dedicating a research building in her name.

Cancer cells are capable of escaping chemotherapy and radiotherapy by activating a signaling pathway that prevents them from dying. Researchers led by Claus Scheidereit at the Max Delbrück Center have now described in Cell Chemical Biology two new compounds that block this escape route.

Studies conducted by research teams at the Max Delbrück Center and its partner institutions used a total of 54,402 animals in 2022. The Center has now submitted these figures to the Berlin State Office for Health and Social Affairs (LaGeSo).

Michael Bader has received over half a million euros from the LEO Foundation. The funding will help him develop a therapy for vitiligo and other inflammatory skin conditions. He hopes the answer lies in an ointment that inhibits ACE2, an enzyme that gained global attention during the coronavirus pandemic.

Armaghan Naghipour, State Secretary for Science, Research and Equality, informed herself about the development of the Berlin-Buch Science and Biotech Campus on February 10, 2023.

And a celebration it was: After two years of virtual graduation ceremonies due to Covid-19, doctoral students at the Max Delbrück Center were once again able to receive their graduation certificates live on stage.

BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking the TSG101 protein hinders these tumor cells from carrying out repair processes.

Almost all human cells are equipped with the chloride ion channel ASOR. But what for? It is essential for the shrinkage of particularly large vesicles - and thus influences certain immune and cancer cells, the FMP and MDC team around Thomas Jentsch now reports in Nature Cell Biology.